Related Experiment Videos

T cell functions in infants and children with beta-thalassemia

A S Khalifa1, Z Maged, R Khalil

  • 1Department of Paediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Acta Haematologica
|January 1, 1988
PubMed

Insights

Beta-thalassemia major patients show lower T cell counts, impacting cell-mediated immunity. This immune dysfunction, particularly in those with infections, suggests increased susceptibility to illness.

Area of Science:

  • Immunology
  • Hematology
  • Pediatrics

Background:

  • Beta-thalassemia is a genetic blood disorder affecting hemoglobin production.
  • Cell-mediated immunity plays a crucial role in defending against infections.
  • Understanding immune status in thalassemia is vital for managing complications.

Purpose of the Study:

  • To investigate cell-mediated immunity in children with beta-thalassemia major and trait.
  • To identify immune alterations associated with disease severity and complications.

Main Methods:

  • Studied 35 children with beta-thalassemia major and 12 with trait.
  • Assessed T lymphocyte subsets (OKT3, OKT4, OKT8), spontaneous and total rosettes (E1-RFC, E2-RFC).
  • Evaluated migration inhibition factor (MIF) assay and delayed hypersensitivity skin reactions.

Main Results:

  • Lower mean T cell counts observed in beta-thalassemia major, not trait.
  • Decreased helper/suppressor T cell ratio in patients with hypersplenism.
  • Patients with pneumonia or hepatitis had reduced T cells, helper cells, and impaired skin reactions/MIF activity.

Conclusions:

  • Cell-mediated immunity is compromised in children with beta-thalassemia major.
  • Immune deficits correlate with disease complications like infections.
  • Assessing cell-mediated immunity may help identify at-risk thalassemia patients.

Related Concept Videos